Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Latest News

  • 1
    News

    Thyroid hormone analogues can reverse NASH

    April 27, 2021

    In patients with nonalcoholic steatohepatitis (NASH) and stages 1-3 fibrosis, does the thyroid hormone receptor beta-agonist, resmetirom reduce hepatic steatosis compared with placebo?

  • 1
    News

    Efficacy and safety of daily low-dose colchicine after recent MI

    April 26, 2021

    Can giving low-dose colchicine to patients after a recent myocardial infarction reduce future ischemic cardiovascular events, compared with placebo?

  • 1
    News

    Feds lift pause of J&J COVID vaccine, add new warning

    April 23, 2021

    The warning is directed at women under the age of 50.

  • 1
    News

    Study: COVID-19 can kill months after infection

    April 23, 2021

    The risk of death is increased up to 6 months after they catch the virus.

  • News

    Can we get to ‘COVID zero’? Experts predict the next 8 months

    April 23, 2021

    “Right now, we are projecting the United States all the way to Aug. 1 [will have] 619,000 deaths from COVID-19, with 4.7 million globally,” said Ali H. Mokdad, PhD.

  • 1
    News

    Lower target LDL-C cuts risk of CV events in ischemic stroke patients

    April 23, 2021

    Is a target LDL cholesterol (LDL-C) level of less than 70 mg/dL superior to a target LDL-C level of 90-110 mg/dL in prevention of future cardiovascular (CV) events in patients with a prior stroke of atherosclerotic origin or transient ischemic attack (TIA)?

  • News

    Percentage of doctors who are Black barely changed in 120 years

    April 23, 2021

    A study also found a significant wage gap between Black and White physicians.

  • 1
    News

    COVID-19 infection conveys imperfect immunity in young adults

    April 23, 2021

    One in 10 Marine recruits with prior SARS-CoV-2 infections were reinfected during basic training.

  • 1
    News

    U.S. Surgeon General Vivek Murthy to Speak at SHM Converge

    April 22, 2021

    Dr. Murthy will discuss burnout and well-being in health care, key themes of the conference, during a fireside chat with Dr. Danielle Scheurer.

  • 1
    News

    COVID plus MI confers poor prognosis; 1 in 3 die in hospital

    April 22, 2021

    National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.

Previous1 … 118 119 120 121 122 … 358Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences